First Time Loading...

hVIVO PLC
LSE:HVO

Watchlist Manager
hVIVO PLC Logo
hVIVO PLC
LSE:HVO
Watchlist
Price: 28.25 GBX -1.22% Market Closed
Updated: Apr 29, 2024

Intrinsic Value

hVIVO PLC provides pharmaceutical development services. [ Read More ]

The intrinsic value of one HVO stock under the Base Case scenario is 24.29 GBX. Compared to the current market price of 28.25 GBX, hVIVO PLC is Overvalued by 14%.

Key Points:
HVO Intrinsic Value
Base Case
24.29 GBX
Overvaluation 14%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
hVIVO PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling HVO stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
hVIVO PLC

Provide an overview of the primary business activities
of hVIVO PLC.

What unique competitive advantages
does hVIVO PLC hold over its rivals?

What risks and challenges
does hVIVO PLC face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for hVIVO PLC.

Provide P/S
for hVIVO PLC.

Provide P/E
for hVIVO PLC.

Provide P/OCF
for hVIVO PLC.

Provide P/FCFE
for hVIVO PLC.

Provide P/B
for hVIVO PLC.

Provide EV/S
for hVIVO PLC.

Provide EV/GP
for hVIVO PLC.

Provide EV/EBITDA
for hVIVO PLC.

Provide EV/EBIT
for hVIVO PLC.

Provide EV/OCF
for hVIVO PLC.

Provide EV/FCFF
for hVIVO PLC.

Provide EV/IC
for hVIVO PLC.

Show me price targets
for hVIVO PLC made by professional analysts.

What are the Revenue projections
for hVIVO PLC?

How accurate were the past Revenue estimates
for hVIVO PLC?

What are the Net Income projections
for hVIVO PLC?

How accurate were the past Net Income estimates
for hVIVO PLC?

What are the EPS projections
for hVIVO PLC?

How accurate were the past EPS estimates
for hVIVO PLC?

What are the EBIT projections
for hVIVO PLC?

How accurate were the past EBIT estimates
for hVIVO PLC?

Compare the revenue forecasts
for hVIVO PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of hVIVO PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of hVIVO PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of hVIVO PLC compared to its peers.

Compare the P/E ratios
of hVIVO PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing hVIVO PLC with its peers.

Analyze the financial leverage
of hVIVO PLC compared to its main competitors.

Show all profitability ratios
for hVIVO PLC.

Provide ROE
for hVIVO PLC.

Provide ROA
for hVIVO PLC.

Provide ROIC
for hVIVO PLC.

Provide ROCE
for hVIVO PLC.

Provide Gross Margin
for hVIVO PLC.

Provide Operating Margin
for hVIVO PLC.

Provide Net Margin
for hVIVO PLC.

Provide FCF Margin
for hVIVO PLC.

Show all solvency ratios
for hVIVO PLC.

Provide D/E Ratio
for hVIVO PLC.

Provide D/A Ratio
for hVIVO PLC.

Provide Interest Coverage Ratio
for hVIVO PLC.

Provide Altman Z-Score Ratio
for hVIVO PLC.

Provide Quick Ratio
for hVIVO PLC.

Provide Current Ratio
for hVIVO PLC.

Provide Cash Ratio
for hVIVO PLC.

What is the historical Revenue growth
over the last 5 years for hVIVO PLC?

What is the historical Net Income growth
over the last 5 years for hVIVO PLC?

What is the current Free Cash Flow
of hVIVO PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for hVIVO PLC.

Financials

Balance Sheet Decomposition
hVIVO PLC

Current Assets 52m
Cash & Short-Term Investments 37m
Receivables 14.6m
Other Current Assets 426k
Non-Current Assets 31.2m
PP&E 20m
Intangibles 5.7m
Other Non-Current Assets 5.5m
Current Liabilities 35.2m
Accounts Payable 34.2m
Other Current Liabilities 952k
Non-Current Liabilities 13.7m
Long-Term Debt 12.2m
Other Non-Current Liabilities 1.6m
Efficiency

Earnings Waterfall
hVIVO PLC

Revenue
56m GBP
Operating Expenses
-45.7m GBP
Operating Income
10.3m GBP
Other Expenses
5.8m GBP
Net Income
16.1m GBP

Free Cash Flow Analysis
hVIVO PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

HVO Profitability Score
Profitability Due Diligence

hVIVO PLC's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional 3-Years Revenue Growth
Positive Free Cash Flow
Exceptional ROE
67/100
Profitability
Score

hVIVO PLC's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

HVO Solvency Score
Solvency Due Diligence

hVIVO PLC's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
High Altman Z-Score
Long-Term Solvency
65/100
Solvency
Score

hVIVO PLC's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HVO Price Targets Summary
hVIVO PLC

Wall Street analysts forecast HVO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HVO is 34.61 GBX with a low forecast of 29.29 GBX and a high forecast of 39.9 GBX.

Lowest
Price Target
29.29 GBX
4% Upside
Average
Price Target
34.61 GBX
23% Upside
Highest
Price Target
39.9 GBX
41% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

HVO Price
hVIVO PLC

1M 1M
-3%
6M 6M
+47%
1Y 1Y
+79%
3Y 3Y
-32%
5Y 5Y
+996%
10Y 10Y
+35%
Annual Price Range
28.25
52w Low
14.25
52w High
30.5
Price Metrics
Average Annual Return 116.84%
Standard Deviation of Annual Returns 225.43%
Max Drawdown -81%
Shares Statistics
Market Capitalization 192.2m GBX
Shares Outstanding 680 371 968
Percentage of Shares Shorted
N/A

HVO Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

hVIVO PLC Logo
hVIVO PLC

Country

United Kingdom

Industry

Life Sciences Tools & Services

Market Cap

192.2m GBP

Dividend Yield

0.7%

Description

hVIVO PLC provides pharmaceutical development services. The firm is engaged in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The company provides end-to-end early clinical development services to its client base, which includes global biopharma companies. The company offers a portfolio of approximately 10+ human challenge models to test a range of infectious and respiratory disease products, challenge agent manufacturing, specialist drug development, and clinical consultancy services via its Venn Life Sciences brand, and a lab offering via its hLAB brand, which includes virology, immunology biomarker and molecular testing. The company offers additional clinical field trial services, such as patient recruitment and clinical trial site services. The company runs challenge studies in from its Whitechapel quarantine clinic, and its QMB clinic with its specialized on-site virology and immunology laboratory.

Contact

London
Queen Mary BioEnterprises Innovation Centre, 42 New Road
+442890737900
https://hvivo.com/

IPO

2012-12-14

Employees

235

Officers

CEO & Director
Dr. Yamin Mohammed Khan Ph.D.
CFO & Executive Director
Mr. Stephen Pinkerton
Chief Scientific Officer
Mr. Andrew Catchpole
Chief Commercial Officer
Dr. Maurice N. Treacy Ph.D.
Head of QA
Ms. Teja Marathe-Sarvadikar

See Also

Discover More
What is the Intrinsic Value of one HVO stock?

The intrinsic value of one HVO stock under the Base Case scenario is 24.29 GBX.

Is HVO stock undervalued or overvalued?

Compared to the current market price of 28.25 GBX, hVIVO PLC is Overvalued by 14%.